Literature DB >> 18063593

Recreational drug use: a major risk factor for gastroschisis?

Elizabeth S Draper1, Judith Rankin, Ann M Tonks, Keith R Abrams, David J Field, Michael Clarke, Jennifer J Kurinczuk.   

Abstract

The authors tested the hypothesis that the birth prevalence of gastroschisis is positively associated with use of recreational drugs in early pregnancy. A matched case-control study was carried out in three regions of the United Kingdom over the period January 2001 through August 2003. For each case, three liveborn controls were matched by initial intended place of delivery, region, and maternal age. Maternal hair analysis provided independent verification of recreational drug use. Conditional logistic regression was used to estimate mutually adjusted odds ratios. Estimates were revised using data from hair analysis. Statistically significant adjusted odds ratios for gastroschisis were associated with first-trimester use of 1) any recreational drug (odds ratio (OR) = 2.2, 95% confidence interval (CI): 1.2, 4.3) and 2) vasoconstrictive recreational drugs (defined as cocaine, amphetamines, and ecstasy) (OR = 3.3, 95% CI: 1.0, 10.5). Other significant exposures included aspirin use (OR = 20.4, 95% CI: 2.2, 191.5), cigarette smoking (OR = 1.7, 95% CI: 1.1, 2.6), and prior history of gynecologic infection/disease (OR = 2.6, 95% CI: 1.2, 5.6). Recreational drug use is a significant risk factor for gastroschisis and is one of a constellation of potentially preventable exposures which include cigarette smoking, aspirin use, and history of gynecologic infection/disease. Maternal hair analysis proved an acceptable and valuable method of independently verifying recreational drug use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063593     DOI: 10.1093/aje/kwm335

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

Review 1.  Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature.

Authors:  Polina Frolov; Jasem Alali; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2010-08-31       Impact factor: 1.827

2.  Risk factors for gastroschisis.

Authors:  Pierpaolo Mastroiacovo
Journal:  BMJ       Date:  2008-06-16

Review 3.  Teratogens inducing congenital abdominal wall defects in animal models.

Authors:  Dennis R Van Dorp; John M Malleis; Brian P Sullivan; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

4.  Trends in incidence and outcomes of gastroschisis in the United States: analysis of the national inpatient sample 2010-2014.

Authors:  Parth Bhatt; Anusha Lekshminarayanan; Keyur Donda; Fredrick Dapaah-Siakwan; Badal Thakkar; Sumesh Parat; Shilpi Chabra; Zeenia Billimoria
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

5.  A machine learning approach to investigate potential risk factors for gastroschisis in California.

Authors:  Kari A Weber; Wei Yang; Suzan L Carmichael; Amy M Padula; Gary M Shaw
Journal:  Birth Defects Res       Date:  2018-12-26       Impact factor: 2.344

Review 6.  Illicit substance use in pregnancy - a review.

Authors:  Katherine Scott; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

7.  Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.

Authors:  Martha M Werler; Samantha E Parker; Klaus Hedman; Mika Gissler; Annukka Ritvanen; Heljä-Marja Surcel
Journal:  Am J Epidemiol       Date:  2016-11-17       Impact factor: 4.897

Review 8.  Neuro-obstetrics: A multidisciplinary approach to care of women with neurologic disease.

Authors:  Ingrid A Brussé; Anna C M Kluivers; Maria D Zambrano; Kara Shetler; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

Review 9.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

10.  Short interpregnancy interval and gastroschisis risk in the National Birth Defects Prevention Study.

Authors:  Kelly D Getz; Marlene T Anderka; Martha M Werler; Amy P Case
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.